Cabot Corp income statement CBT

In Q3 of fiscal 2026, the quarter ended Jun 30, 2026, Cabot Corp reported revenue of $982.0 million, up 6.4% from the same quarter a year earlier. Net income was $6.0 million, a profit margin of 0.6%. Operating income came to $98.0 million, an operating margin of 10.0%. Diluted earnings per share were $0.12.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Jun 30, 2026
Q3 FY2026
Jun 30, 2026
Q2 FY2026
Mar 31, 2026
Q1 FY2026
Dec 31, 2025
Q4 FY2025
Sep 30, 2025
Q3 FY2025
Jun 30, 2025
Q2 FY2025
Mar 31, 2025
Q1 FY2025
Dec 31, 2024
Q4 FY2024
Sep 30, 2024
Revenue
3,634
-4.7%
982
+6.4%
904
-3.4%
849
-11.1%
899
-10.2%
923
-9.2%
936
-8.1%
955
-0.3%
1,001
+3.7%
Cost of revenue
2,809
-1.6%
798
+17.5%
694
-0.1%
638
-11.4%
679
-10.8%
679
-10.7%
695
-10.1%
720
-2.7%
761
+2.8%
Gross profit
825
-14.1%
184
-24.6%
210
-12.9%
211
-10.2%
220
-8.3%
244
-4.7%
241
-2.0%
235
+7.8%
240
+6.7%
Research and development
55
-9.8%
13
-13.3%
14
-6.7%
13
-7.1%
15
-11.8%
15
-6.2%
15
+0.0%
14
-6.7%
17
+21.4%
Selling, general and administrative
277
+4.5%
73
+17.7%
67
+4.7%
69
+4.5%
68
-6.8%
62
-8.8%
64
-14.7%
66
-1.5%
73
+5.8%
Restructuring and impairment
—
42
8
7
—
—
—
—
0
Operating income
493
-22.2%
98
-41.3%
129
-20.4%
129
-16.8%
137
-8.7%
167
-2.9%
162
+3.8%
155
+14.0%
150
+5.6%
Pretax income
411
-29.7%
58
-62.6%
120
-20.5%
118
-18.1%
115
-14.8%
155
-1.9%
151
+6.3%
144
+53.2%
135
+6.3%
Income tax
190
+54.5%
46
+7.0%
44
-10.2%
37
-9.8%
63
+730.0%
43
+7.5%
49
+4.3%
41
+20.6%
-10
+91.5%
Net income
190
-55.3%
6
-94.1%
68
-27.7%
73
-21.5%
43
-68.6%
101
-7.3%
94
+11.9%
93
+86.0%
137
-41.5%
Basic EPS
3.57
-53.8%
0.12
-93.6%
1.27
-25.7%
1.38
-18.3%
0.79
-67.8%
1.87
-4.6%
1.71
+14.0%
1.69
+92.0%
2.46
-40.4%
Diluted EPS
3.55
-53.6%
0.12
-93.5%
1.27
-24.9%
1.37
-18.0%
0.78
-67.6%
1.86
-4.1%
1.69
+13.4%
1.67
+89.8%
2.42
-41.2%
Weighted average shares, basic
52
-3.1%
52
-3.6%
52
-3.7%
53
-2.9%
53
-2.6%
54
-2.9%
54
-2.5%
54
-1.8%
55
-2.3%
Weighted average shares, diluted
53
-3.6%
52
-3.3%
52
-4.0%
53
-3.8%
54
-3.2%
54
-3.4%
54
-2.5%
55
-1.4%
55
-0.9%
Other measures
Depreciation and amortization
180
+19.2%
50
+28.2%
49
+28.9%
41
+10.8%
40
+8.1%
39
+8.3%
38
+2.7%
37
-9.8%
37
+0.0%
EBITDA
673
-14.3%
148
-28.2%
178
-11.0%
170
-11.5%
177
-5.3%
206
-1.0%
200
+3.6%
192
+8.5%
187
+4.5%
Interest coverage
6.66x
5.44x
7.17x
7.17x
6.85x
8.79x
8.53x
8.61x
7.89x
Margins
Gross margin
22.70%
18.74%
23.23%
24.85%
24.47%
26.44%
25.75%
24.61%
23.98%
Operating margin
13.57%
9.98%
14.27%
15.19%
15.24%
18.09%
17.31%
16.23%
14.99%
Pretax margin
11.31%
5.91%
13.27%
13.90%
12.79%
16.79%
16.13%
15.08%
13.49%
Profit margin
5.23%
0.61%
7.52%
8.60%
4.78%
10.94%
10.04%
9.74%
13.69%
EBITDA margin
18.52%
15.07%
19.69%
20.02%
19.69%
22.32%
21.37%
20.10%
18.68%
Effective tax rate
46.23%
79.31%
36.67%
31.36%
54.78%
27.74%
32.45%
28.47%
-7.41%
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Miscellaneous Chemical Products (SIC 2890)
Listed as
CBT (NYSE)
Fiscal year ends
September 30
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Large accelerated filer
SEC CIK
16040
Former names
CABOT CORP (until Nov 2, 2026)

Other Miscellaneous Chemical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.